The present disclosure relates to the technical field of pharmaceutical preparations, and provides a pharmaceutical preparation containing
pranoprofen and a preparation method thereof. 5H-[1]-benzopyrano[2,3-b]
pyridine-5-one is subjected to a reduction reaction and a dehydroxylation conversion to obtain 5H-[1]-benzopyrano[2,3-b]
pyridine; the 5H-[1]-benzopyrano[2,3-b]
pyridine is subjected to an
acylation reaction to obtain a 2-halogenated propionyl substituted benzopyranopyridine intermediate; the 2-halogenated propionyl substituted benzopyranopyridine intermediate is treated to obtain crude
pranoprofen; the crude
pranoprofen is subjected to recrystallization to obtain pranoprofen wet crystals, and the pranoprofen wet crystals are added into an
aqueous dispersion solvent to obtain the pharmaceutical preparation containing pranoprofen. The adverse effects of
impurity accumulation in the synthesis process in the early stage are reduced, and the
dispersion stability of the preparation in the later stage is improved, so that the
dispersion stability of the preparation from the early stage to the later stage is realized.